HLB Genex CEO Kim Doyeon Purchases Company Shares on Market... "Demonstrates Responsible Management"

Kim Doyeon, CEO of HLB Genex, demonstrated his commitment to responsible management by purchasing shares on the open market.

According to HLB Genex on April 21, CEO Kim acquired 15,556 shares on the previous day through on-market trading, increasing his total holdings to 38,646 shares. This share purchase is interpreted as a move reflecting strong confidence, stemming from the solid performance growth of the company's core business amid the recent semiconductor industry boom, as well as the smooth progress in global new drug development projects being advanced through its subsidiaries.

In particular, following last week’s move by Jin Yanggon, Chairman of HLB Group, to increase his stake in HLB Genex after highly valuing the company's turnaround and the growth potential of its main business, the CEO’s immediate participation in share purchases has been seen as reaffirming the top management’s firm confidence in the company’s future value to the market.

The consecutive share purchases are backed by two powerful drivers: a "stable core business" and a "new business with explosive potential." In its core business, HLB Genex’s essential enzyme business for semiconductor processing—a key cash cow—is providing stable support for first-quarter results. The ongoing favorable global semiconductor market continues to bring related benefits, and the resulting revenue and profits are serving as a financial foundation for future business expansion. In addition, Neurotov, a subsidiary and future growth engine, is strengthening the development of treatments for degenerative brain diseases.

CEO Kim stated, "While the chairman’s share purchase demonstrated the group’s trust in the company’s improved fundamentals and growth direction, this purchase reflects my own sense of responsibility and confidence as CEO to ensure that these goals are realized at the frontline of operations."

This content was produced with the assistance of AI translation services.